Eisai
4523.T
#2145
Rank
NZ$16.02 B
Marketcap
NZ$56.79
Share price
3.73%
Change (1 day)
11.92%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$5.88 Billion

According to Eisai's latest financial reports the company's total liabilities are NZ$5.88 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31NZ$5.28 B-4.43%
2022-03-31NZ$5.52 B17.63%
2021-03-31NZ$4.70 B-15.94%
2020-03-31NZ$5.59 B0.95%
2019-03-31NZ$5.53 B-2.03%
2018-03-31NZ$5.65 B3.52%
2017-03-31NZ$5.46 B6.95%
2016-03-31NZ$5.10 B1.01%
2015-03-31NZ$5.05 B1.56%
2014-03-31NZ$4.97 B-23.8%
2013-03-31NZ$6.53 B-23.54%
2012-03-31NZ$8.54 B-15.02%
2011-03-31NZ$10.05 B-2.16%
2010-03-31NZ$10.27 B-19.36%
2009-03-31NZ$12.74 B52.65%
2008-03-31NZ$8.34 B206.63%
2007-03-31NZ$2.72 B-14.9%
2006-03-31NZ$3.19 B20.06%
2005-03-31NZ$2.66 B-5.58%
2004-03-31NZ$2.82 B-9.37%
2003-03-31NZ$3.11 B-1.83%
2002-03-31NZ$3.17 B-21.63%
2001-03-31NZ$4.04 B